Biocept Inc. Daily Stock Analysis

Daily Stock Analysis, BIOC, Biocept Inc, priceseries

Biocept Inc. Daily Stock Analysis
Stock Information
Open
2.20
Close
2.04
High
2.21
Low
2.01
Previous Close
2.17
Daily Price Gain
-0.13
YTD High
4.02
YTD High Date
Jan 4, 2022
YTD Low
1.96
YTD Low Date
Feb 24, 2022
YTD Price Change
-1.93
YTD Gain
-48.61%
52 Week High
6.40
52 Week High Date
Mar 30, 2021
52 Week Low
1.96
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-3.06
52 Week Gain
-60.00%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 5. 2017
270.00
Jan 18. 2017
464.17
8 Trading Days
71.91%
Link
LONG
Jan 24. 2017
507.00
Jan 25. 2017
535.50
1 Trading Days
5.62%
Link
LONG
Feb 7. 2017
471.00
Feb 17. 2017
591.13
8 Trading Days
25.51%
Link
LONG
May 29. 2018
57.81
Jun 21. 2018
69.93
17 Trading Days
20.97%
Link
LONG
Oct 26. 2018
23.30
Oct 29. 2018
24.75
1 Trading Days
6.22%
Link
LONG
Jan 14. 2019
22.00
Jan 15. 2019
23.75
1 Trading Days
7.95%
Link
LONG
Jan 16. 2019
23.40
Jan 18. 2019
25.50
2 Trading Days
8.97%
Link
LONG
Jan 24. 2019
20.40
Jan 25. 2019
21.85
1 Trading Days
7.11%
Link
LONG
May 20. 2019
16.00
May 21. 2019
18.55
1 Trading Days
15.94%
Link
LONG
Dec 30. 2019
2.70
Jan 10. 2020
3.21
8 Trading Days
19.06%
Link
LONG
Apr 9. 2020
3.56
Apr 15. 2020
3.80
3 Trading Days
6.71%
Link
LONG
May 20. 2020
4.11
May 27. 2020
4.46
4 Trading Days
8.63%
Link
LONG
Jun 3. 2020
4.38
Jun 11. 2020
4.64
6 Trading Days
6.06%
Link
LONG
Jun 12. 2020
5.54
Jun 23. 2020
6.60
7 Trading Days
19.22%
Link
LONG
Jul 30. 2020
7.19
Aug 14. 2020
9.07
11 Trading Days
26.07%
Link
LONG
Oct 1. 2020
4.50
Oct 14. 2020
4.82
9 Trading Days
7.12%
Link
LONG
Nov 10. 2020
4.61
Nov 13. 2020
5.00
3 Trading Days
8.41%
Link
LONG
Jan 11. 2021
5.09
Jan 28. 2021
5.84
12 Trading Days
14.77%
Link
LONG
Feb 3. 2021
6.34
Feb 18. 2021
7.05
10 Trading Days
11.21%
Link
Company Information
Stock Symbol
BIOC
Exchange
NasdaqCM
Company URL
http://www.biocept.com
Company Phone
858-320-8200
CEO
Michael W. Nall
Headquarters
California
Business Address
5810 NANCY RIDGE DR, SAN DIEGO, CA 92121
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001044378
About

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.

Description

Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The company's cancer assays provide information to oncologists and other physicians that enable them to select personalized treatment for their patients who have been diagnosed with cancer based on molecular drivers. It offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, and melanoma. The company sells its cancer diagnostic assays directly to oncologists and other physicians at private and group practices, hospitals, and cancer centers in the United States, as well as markets its clinical trial and research services to pharmaceutical and biopharmaceutical companies, and clinical research organizations. Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading